Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2016-09-30
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Optimise Diet is a multi-pronged diet based on "best health" principles: to minimise blood glucose rises after eating, reduce the immune cells involved in destruction of the insulin-secreting beta-cells, and improve the gut microbiome and systemic inflammation. In this study, its effects will be compared to the Standard Diabetes Diet that is currently recommended in Australia and internationally.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carvedilol in Treating Hypoglycemia Unawareness
NCT03538015
Liraglutide in Type 1 Diabetes
NCT01612468
Circulating Biomarkers in the Development of Type 1 Diabetes
NCT05505669
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
NCT03632759
Liraglutide as add-on to Insulin in Type 1 Diabetes
NCT02092896
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Novel type 1 diet
Experimental diet to be examined: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus.
Novel diet
Novel diet to optimise glucose levels and minimise systemic inflammation: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus.
Standard therapy
Standard dietary therapy, as promulgated by Australian standards
Standard diet
Standard diabetes diet recommendations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Novel diet
Novel diet to optimise glucose levels and minimise systemic inflammation: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus.
Standard diet
Standard diabetes diet recommendations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Garvan Institute of Medical Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Katherine Samaras
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katherine Samaras, MD PhD FRACP
Role: PRINCIPAL_INVESTIGATOR
Garvan Institute of Medical Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
professor Katherine Samaras
Sydney, New South Wales, Australia
Garvan Institute to Medical Research
Sydney, , Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16/053
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.